Financing channel feed – Endpoints News

Financing channel feed

Illumina co-founder Mark Chee moves from the genome to the proteome with upstart Encodia

5 years ago

One of the most ambitious startup teams in biotech just outlined plans for a $400M IPO and a valuation of about $4B

5 years ago

Leaps by Bayer backs a protein engineering startup taking on Aimmune — and Nestlé — in peanut allergy

5 years ago

As targeted therapies get ever more precise, Deerfield unveils $50M bet on a Harvard professor's chemistry insights

5 years ago

Ex-MD Anderson chief DePinho is helping launch another biotech — and he's sticking with familiar ground

5 years ago

Harvard spinout kicks off 2021 with a crossover round and sights set on the clinic

5 years ago

Plexium adds industry vet Mike Grey to the brain trust with new investor cash funding its protein degradation play

5 years ago

The IPO flood keeps rising with 4 more biotechs and a SPAC on their way to Nasdaq

5 years ago

The IPO queue adds 5 more biotechs hoping to ring in 2021 by blitzing Nasdaq

5 years ago

'Bluest of blue-chip investors' pump $94M into Sekar Kathiresan's quest to bring CRISPR to the heart

5 years ago

An ambitious GV-backed gene editing upstart re-emerges as a one-drug kidney company

5 years ago

A cardiovascular cell therapy player grabs $54M for a new beginning — where next-gen CAR-T approach features prominently

5 years ago

Eli Lilly re-ups diversity pledge, pitching in $30M to venture fund for minority-owned healthcare firms

5 years ago

With its rank-and-file churning out startups, Dana-Farber launches venture fund to capitalize on that success

5 years ago

As venture funding in oncology flourishes, neuro has seen shallower pockets. A European investor wants to change that

5 years ago

Fujifilm doubles down on Boston foothold, renting some major legroom to chase cell and gene therapies

5 years ago

Chris Garabedian's first Xontogeny company, Landos Biopharma, preps a nine-figure IPO as lead program heads to PhIII

5 years ago

Painting by the numbers, Sana founders carve up a giant unicorn-sized IPO — for a biotech that hasn't quite made it to the clinic

5 years ago

Pfizer's investment fund is making waves in VC — including a $25M bet on IBD player Vedanta Biosciences

5 years ago

IDO on the rebound? Danish outfit IO Biotech hopes so with oversubscribed Series B one month after BTD in melanoma

5 years ago

With a torrent of venture cash gushing from a global pack of unicorn hunters, this biotech founder vows to stay hungry

5 years ago

Looking to blend AI and human data, Valo Health scores new financing to test drug discovery platform in oncology, beyond

5 years ago

Hot on the heels of a positive PhIII, Immunocore hauls in $175M as it hunts its first TCR OK

5 years ago

Genentech and Biogen roll the dice on an upstart biotech with a new siRNA approach — going deep into the brain for targets in neurodegeneration

5 years ago

First page Previous page 83 84 858687 88 89 Next page Last page